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Background: Klebsiella pneumoniae is an important opportunistic pathogen associated with nosocomial and
community-acquired infections. A wide repertoire of virulence and antimicrobial resistance genes is present in
K. pneumoniae genomes, which can constitute extra challenges in the treatment of infections caused by some
strains. K. pneumoniae Kp13 is a multidrug-resistant strain responsible for causing a large nosocomial outbreak in a
teaching hospital located in Southern Brazil. Kp13 produces K. pneumoniae carbapenemase (KPC-2) but is unrelated to
isolates belonging to ST 258 and ST 11, the main clusters associated with the worldwide dissemination of KPC-producing
K. pneumoniae. In this report, we perform a genomic comparison between Kp13 and each of the following three
K. pneumoniae genomes: MGH 78578, NTUH-K2044 and 342.
Results: We have completely determined the genome of K. pneumoniae Kp13, which comprises one chromosome
(5.3 Mbp) and six plasmids (0.43 Mbp). Several virulence and resistance determinants were identified in strain
Kp13. Specifically, we detected genes coding for six beta-lactamases (SHV-12, OXA-9, TEM-1, CTX-M-2, SHV-110 and
KPC-2), eight adhesin-related gene clusters, including regions coding for types 1 (fim) and 3 (mrk) fimbrial adhesins.
The rmtG plasmidial 16S rRNA methyltransferase gene was also detected, as well as efflux pumps belonging to five
different families. Mutations upstream the OmpK35 porin-encoding gene were evidenced, possibly affecting its
expression. SNPs analysis relative to the compared strains revealed 141 mutations falling within CDSs related to
drug resistance which could also influence the Kp13 lifestyle. Finally, the genetic apparatus for synthesis of the
yersiniabactin siderophore was identified within a plasticity region. Chromosomal architectural analysis allowed for
the detection of 13 regions of difference in Kp13 relative to the compared strains.
Conclusions: Our results indicate that the plasticity occurring at many hierarchical levels (from whole genomic
segments to individual nucleotide bases) may play a role on the lifestyle of K. pneumoniae Kp13 and underlie the
importance of whole-genome sequencing to study bacterial pathogens. The general chromosomal structure was
somewhat conserved among the compared bacteria, and recombination events with consequent gain/loss of
genomic segments appears to be driving the evolution of these strains.
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Klebsiella pneumoniae is a non-motile, rod-shaped,
Gram-negative bacterium belonging to the Enterobacte-
riaceae family. It occupies diverse ecological niches ran-
ging from soil to water, but from an anthropocentric
perspective it represents one of the most important
human pathogens [1,2]. K. pneumoniae are commonly
reported as etiologic agents of either community-
acquired urinary tract infections or bacterial pneumonia.
However, it can cause any type of infection in hospital
settings, including outbreaks in newborns and adults
under intensive care, which is likely associated to its
ability to spread rapidly in the hospital environment [1].
A wide repertoire of virulence and resistance factors
is present in K. pneumoniae genomes, allowing for the
expression of capsule, siderophores, adhesins and anti-
microbial resistance determinants [3,4].
At present, six complete K. pneumoniae subsp. pneu-
moniae genomes are available on the public databases,
namely K. pneumoniae strains MGH 78578 (multidrug-
resistant [MDR] bacterium isolated from a patient with
pneumonia [5]), NTUH-K2044 (a hypermucoviscosity
(HV)-positive isolate obtained from a patient with liver
abscess and meningitis [3]), 342 (N2-fixer plant endo-
phyte still bearing pathogenic potential against mice
[4]), HS11286 (MDR clinical isolate [6]), KCTC 2242
(a 2,3-butanediol producer [7]) and 1084 (an HV-negative
clinical isolate causing liver abscess [8]). Other 115 on-
going K. pneumoniae sequencing projects are available as
scaffolds/contigs at the NCBI Genome database (http://
www.ncbi.nlm.nih.gov/genome/genomes/815). The avail-
ability of closed genomes is important towards under-
standing the K. pneumoniae genome plasticity and the
evolutionary forces that drive their genetic differentiation
and occupation of distinct ecological niches. For instance,
Wu et al. [3] showed that the methionine salvage pathway,
which might have a role in pathogenesis via oxidative
stress, is present in all Klebsiella genomes but not in
Escherichia, Salmonella or Shigella, thus providing diver-
sity in virulence mechanisms in pathogenic enterobacteria.
Moreover, from the comparative genomic analyses be-
tween strains 342 and MGH 78578, Fouts et al. [4] identi-
fied variations in the distribution of genes related to
surface attachment, regulation and signaling, secretion
and transport, all of which may have important implica-
tions concerning their preferred lifestyle and host ranges
(endophytic plant associations for 342 and human patho-
gen for MGH 78578).
Among the antimicrobial resistance repertoire of K. pneu-
moniae, the production of carbapenemase is particularly
worrisome since it confers resistance to all beta-lactams.
KPC (Klebsiella pneumoniae carbapenemase) is the main
Ambler’s class A carbapenemase found in this species,
representing an emerging public health issue in manycountries like USA, Greece, Israel, and Brazil [9]. Interest-
ingly, it has been shown that the worldwide dissemination
of KPC-producing K.pneumoniae occurred due to the
expansion of ancestrally-related isolates comprising the
Clonal Complex 11 (CC11). Even though representatives
of KPC producing CC11 have also successfully dissemi-
nated in Brazil, many KPC-2 producers reported in that
country are not related to this epidemic lineage [10,11].
In May 2009, K. pneumoniae isolate Kp13 (hereafter
referred as Kp13) was obtained from the blood culture
of a patient admitted to the intensive care unit (ICU)
of a teaching hospital located in the city of Londrina,
Southern Brazil. Kp13 was one of the representative
strains of a clone that caused a nosocomial outbreak in
that hospital that involved 18 ICU patients. It was the
first time KPC producers were identified in that health-
care institution. Of notice, nearly 60% of cases died in
average within 18 days after KPC-producing K. pneumo-
niae isolate was recovered. Although this outbreak was
due to the clonal dissemination of KPC-producing iso-
lates, Kp13 showed a distinguished antimicrobial suscep-
tibility profile, expressively more resistant than the other
isolates (Eliana C. Vespero, personal communication).
In addition, it was previously reported that Kp13 pos-
sesses a unique capsular gene cluster, cpsKp13, among the
approximately 80 capsular serotypes described to date [12].
The genome of Kp13 was fully sequenced and showed
to be constituted by one chromosome and six plasmids.
To our best knowledge, it represents the first available
complete and closed genome of a K. pneumoniae isolated
from Latin America, as well as the first one of a K. pneumo-
niae responsible for causing a large nosocomial outbreak.
In this report, we perform a genomic comparison be-
tween Kp13 and three K. pneumoniae genomes (MGH
78578, NTUH-K2044 and 342), to gain insights into the
resistance and virulence repertoire of this strain, its
unique/shared gene content relative to the compared
strains and plasticity regions that may be circulating in
other clinically relevant bacteria.
Results and discussion
General genomic features of K. pneumoniae isolate Kp13
MLST analysis classified Kp13 under the ST 442, sharing
a single alelle with both ST 258 and ST 11, the main
clusters associated with the worldwide dissemination
of KPC-producing K. pneumoniae. Of notice, clinical
isolates belonging to ST 442 have been only identified in
Brazil so far [10,11].
The complete genome of K. pneumoniae isolate Kp13
consists of 5,739,888 bp of which 5,307,003 bp form a
single, circular chromosome (Figure 1) and 432,885 bp
are split into six plasmids which range in size from
2,459 bp (pKP13a) to 294,493 bp (pKP13f) (Table 1). All
the replicons were completely closed and the putative
Figure 1 Circular map of the chromosome of K. pneumoniae Kp13 and related bacteria. The innermost ring represents the K. pneumoniae
Kp13 chromosome used as reference and its coordinates. The second ring (in black) plots the G + C content of the reference, followed by its
G + C skew (in purple/green). Red, cyan and green rings that follow depict BLASTN comparisons between the chromosomes of Kp13 and those
of strains MGH 78578, NTUH-K2044 and 342, respectively. The outermost, interspaced rings (in orange) represent the localization of the predicted
regions of genomic plasticity in the Kp13 chromosome, and the labels of each region follow the ones in Table 2.
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reported sequence data can be obtained from the NCBI
(http://www.ncbi.nlm.nih.gov/bioproject) under project
accession ID PRJNA78291.
The G + C content of the Kp13 chromosome is 57.5%,
which is in agreement with values previously reported
for NTUH-K2044 (57.7%), MGH 78578 (57.5%) and 342
(57.3%) (Table 1). However, the plasmidial sequences
present a much lower G + C content of 49.1 ± 4.4%
(mean and standard deviation for the six replicons) sug-
gesting the existence of DNA acquired during events of
horizontal gene transfer (HGT), an observation that is
corroborated by the number of mobile genetic elements
(MGEs) such as transposons and phage sequences found
in these plasmids. The number of transfer RNAs (tRNAs)
identified in Kp13 was 86, which is identical to those of
MGH 78578 and NTUH-K2044, but different than thatreported in the strain 342 that carries 88 tRNAs genes
(Table 1). Regarding the chromosome size, Kp13 lies be-
tween the human pathogens NTUH-K2044 and MGH
78578 [3], while K. pneumoniae 342 presents the largest
chromosome size (Table 1). This is probably due to the
accumulation of genes related to its adaptation to a dif-
ferent ecological niche since this strain is a N2-fixing
bacterium [4]. However, when considering only plas-
midial sequences, the DNA content of Kp13 (432,885 bp,
six plasmids) is markedly higher than other compared
strains being followed by MGH 78578 (379,774 bp distrib-
uted among its five plasmids, Table 1). In fact, as it will
be further discussed in this paper, a number of Kp13’s
virulence- and resistance-related genes are plasmid-
mediated and their respective proteins may contribute
for evasion of host defenses and survival under anti-
microbial selective pressure.
Table 1 Main features of the K. pneumoniae Kp13 genome compared to related bacteria
Organism Size (bp) G + C
content (%)
No. of
CDSs‡
Mean CDS
size (bp)
Coding
density (%)
No. of
tRNAs
Reference
K. pneumoniae Kp13
Chromosome 5,307,003 57.5 5,288 896 89.3 86 This study
Plasmids
pKP13a 2,459 49.2 3 553 67.5 0
pKP13b 3,223 56.3 5 505 78.4 0
pKP13c 5,065 43.8 9 350 62.3 0
pKP13d 45,574 46.0 63 590 81.6 0
pKP13e 81,071 51.1 108 636 84.8 0
pKP13f 295,493 47.9 365 682 84.2 0
K. pneumoniae NTUH-K2044
Chromosome 5,248,520 57.7 5,130 939 89.4 86 [3]
Plasmids
pK2044 224,152 50.2 270 696 83.4 0
K. pneumoniae MGH 78578
Chromosome 5,315,120 57.5 4,776 958 86.1 86 Washington University
Plasmids
pKPN3 175,879 51.7 178 756 76.5 0
pKPN4 107,576 53.4 123 726 83.1 0
pKPN5 88,582 53.8 98 694 76.8 0
pKPN6 4,259 41.4 5 551 64.7 0
pKPN7 3,478 45.7 5 343 49.3 0
K. pneumoniae 342
Chromosome 5,641,239 57.3 5,425 915 88.0 88 [4]
Plasmids
pKP187 187,922 47.2 230 608 74.5 0
pKP91 91,096 51.1 113 635 78.8 0
‡Number of CDSs according to the submitted GenBank flatfile downloaded from NCBI for each studied genome.
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pneumoniae
The overall architecture of the chromosomes of K. pneu-
moniae Kp13, NTUH-K2044, MGH 78578 and 342 were
studied using the Mauve tool [13], and these multiple
alignments are shown in Additional file 1. This analysis
evidenced an overall structural conservation and co-
linearity among the chromosomes of the different K.
pneumoniae strains compared. The multiple alignments
showed the existence of nine large locally colinear blocks
(LCBs); however, it was observed that strain-specific
regions were also present within LCBs (white segments
in Additional file 1), which may harbor specific adapta-
tions of each bacterium, as it will be further discussed in
the plasticity segment section. These regions most likely
represent DNA acquired during events of HGT and may
provide a greater metabolic versatility to Kp13 strain [14].
For instance, the chromosome of N2-fixing strain 342
was the one that most accumulated differences relative toother human pathogens (Additional file 1), such as the nif
cluster located in a plasticity region unique to that strain
(KPK_1696-KPK_1715) [4].
Chromosomal inversions are thought to be one of the
main events of genomic rearrangements in bacteria
[15]. Of notice, no recombination events leading to
inversions of DNA segments occurred within the larger
LCBs (Additional file 1). Only LCB2 and LCB4 (both
smaller than 10 kbp) were found inverted relative to the
Kp13 chromosome (Additional file 2). This observation re-
inforces the conserved chromosomal architecture among
the compared K. pneumoniae strains since these strains are
not epidemiologycally related and, in the case of 342, can
be considered ecologically distinct from one another.
Regions of genomic plasticity between Kp13
and other K. pneumoniae
A total of 13 RGPs were identified in Kp13’s chromo-
some when compared to the chromosomes of 342,
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of these regions contain sequences related to transposable
elements, and were flanked by genes coding for tRNAs or
phage-structures (Table 2), which can be regarded as evi-
dences for their horizontal acquisition [16]. The amount
of DNA located in these regions accounts for at least
400.1 kbp or 7.5% of the Kp13 chromosome. The main
characteristics of these RGPs are next discussed, but
additional information is provided as supporting informa-
tion (see Additional file 3).
RGP1 carries an insertion sequence at its 5′-end
(IS1 family, KP05176) and harbors CDSs with predicted
catalytic domains at the protein level including two
possible dioxygenases (KP02716, KP02718) and a de-
hydrogenase (KP02715), which may be involved in the
degradation of aromatic compounds [17], although further
studies will be necessary to confirm this role. RGP2 con-
tains genes for transposases and a possible phage integrase
(KP16268) as well as hypothetical genes which do not
allow for any inference on a possible metabolic role. RGP3
is 41 kbp in length and represents a phage insertion in the
Kp13 chromosome, with the majority of its CDSs sharing
greater identity to those of Salmonella phage SPN1S
[GenBank:NC_016761]. A second, large bacteriophage-
related RGP was detected in the Kp13 chromosome
(RGP9, Table 2) and part of this region exhibits remark-
able sequence similarity to that of K. oxytoca ϕKO2
prophage [18]. Apart from phage sequences, a possible
antibiotic resistance cluster that contains genes coding
for transcriptional regulators (KP04065, KP04061), an
antibiotic biosynthesis monooxygenase (KP04063) and a
glyoxalase/bleomicin dioxygenase (KP04064) were found,
but further experimental studies are warranted to establishTable 2 Regions of Genomic Plasticity (RGPs) identified in the
Region Coordinates Length (kbp) No. of CDSs G + C% Fea
RGP1 748,751 – 764,155 15.4 17 59% s.b.
RGP2 1,031,543 – 1,043,427 11.9 9 37% s.b.
RGP3 1,294,343 – 1,335,472 41.1 55 52% s.b.
RGP4 1,444,954 – 1,481,531 36.6 36 50% s.b.
tran
RGP5 1,827,686 – 1,893,227 65.5 59 53% s.b.
RGP6 2,056,825 – 2,088,335 31.5 35 52% s.b.
RGP7 2,278,838 – 2,293,758 14.9 17 46% s.b.
RGP8 2,961,023 – 2,987,614 26.6 20 60% s.b.
RGP9 3,155,750 – 3,244,119 88.4 111 52% s.b.
RGP10 3,425,935 – 3,436,504 10.6 9 48% s.b.
RGP11 3,898,258 – 3,906,459 8.2 9 54% s.b.
RGP12 4,204,889 – 4,234,405 29.5 33 48% s.b.
RGP13 4,660,071 – 4,695,371 35.3 32 50% s.b.
*BLASTN performed against the ‘nr’ database at the NCBI website; dGC%, deviation
other compared K. pneumoniae; phage, probable bacteriophage region; tRNA, prese
sequences; T4SS/T6SS, presence of, respectively, types IV/VI secretion systems.the relevance of this region to the MDR phenotype dis-
played by Kp13. RGP4 is one of three plasticity segments
containing genes responsible for type VI secretion system
(T6SS) formation. T6SS proteins are part of a recently de-
scribed apparatus that secretes toxins using a needle-like
mechanism [19]. They have been previously implicated in
bacterial pathogenesis such as the HSI-I locus of Pseudo-
monas aeruginosa associated with persistent infections by
this bacteria [20]. A CDS coding for the VgrG protein was
identified in RGP4 (KP01061). This protein may play both
the role of an effector (influencing the target cell physi-
ology) as well as of structural component of the T6SS
where it has been reported to form part of the puncturing
needle [21]. Two other T6SS-related RGPs were detected
in the Kp13 chromosome inside of the RGP6 and RGP8.
RGP6 contains CDSs coding for bacteriocins, proteins that
target other bacteria and may provide competitive advan-
tage to Kp13. In contrast, the third T6SS locus found in
RGP8 harbors the hcp gene (KP04341) whose product,
Hcp, is also part of the needle structure along with VgrG
[21]. It has been shown that Hcp inhibited phagocytosis
by macrophages in Aeromonas hydrophila, thus acting as
an effector in modulating the host’s innate immune re-
sponse [22,23]. A noteworthy plasticity region detected in
the Kp13 chromosome was located in RGP5 (Figure 2),
which has been previously established in other bacteria as
being an ICE (Integrative and Conjugative Element) [24].
The integration of this region into the Kp13 chromosome
could have been facilitated by tRNAs (for asparagine)
located at its flanking termini as has been shown for
other K. pneumoniae [24]. Genes usually involved in
plasmidial mobilization (mobC, KP04798 and mobB,
KP04799) as well as in T4SS (KP04803-KP04813) areK. pneumoniae Kp13 chromosome
tures Best hit (% coverage, e-value)*
; dGC%; transposases K. pneumoniae MGH 78578 (100%, 0.0)
; dGC%; phage; transposases Enterobacter cloacae ATCC 13047 (10%, 0.0)
; dGC%; phage Escherichia coli IHE3034 (23%, 0.0)
; dGC%; T6SS; tRNA;
sposases
Salmonella enterica (55 %, 0.0)
; tRNA; dGC%; T4SS Enterobacter hormaechei (93%, 0.0)
; T6SS; dGC%; transposases K. pneumoniae NTUH-K2044 (85%, 0.0)
; dGC%; transposases K. pneumoniae HS11286 (91%, 0.0)
; T6SS; dGC% K. pneumoniae KCTC 2242 (98%, 0.0)
; dGC%; phage K. pneumoniae MGH 78578 (29%, 0.0)
; dGC%; transposases K. pneumoniae MGH 78578 (75%, 0.0)
; transposases K. pneumoniae MGH 78578 (100%, 0.0)
; dGC%; tRNA; transposases K. pneumoniae KCTC 2242 (43%, 0.0)
; dGC%; tRNA; transposases K. pneumoniae KCTC 2242 (60%, 0.0)
from mean chromosomal GC content; s.b., synteny break from at least one
nce of flanking transfer RNAs; transposases, presence of transposase-related
Figure 2 Genomic context of RGP5 (Yersinia high-pathogenicity island) detected in Kp13. Arrows represent predicted genes and their
respective transcription strands (forward/reverse). In yellow, those that code for T4SS proteins; in blue, genes unique to Kp13; in green, genes
related to siderophore production and export. The central segment unique to NTUH-K2044 contains the iro cluster related to iron capture. In
orange and brown are shown, respectively, integrases and transposases. Plots above each region indicates the corresponding G + C content (%).
The vertical blue and red segments connecting regions represent, respectively, direct or inverted conserved segments (BLASTN≥ 70%).
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this region (Figure 2). A great part of the gene compos-
ition of RGP5 is related to that of Yersinia pestis high-
pathogenicity island (HPI) which is present in many
Enterobacteriaceae genera [24]. The presence of genes
coding for the yersiniabactin siderophores (irp1, KP04825
and irp2, KP04826) are characteristic of this HPI, and their
occurrence in more virulent K. pneumoniae strains has
been previously reported [24]. The presence of this region
is indicative that Kp13 is well adapted as a pathogen, since
iron scavenging is important during infection, as this
nutrient is poorly available in the host in its free form.
Alternative siderophore systems were also found in the
Kp13 genome and will be further detailed. The ICE
region is absent in the clinical strain MGH 78578 as
well as in the N2-fixing strain 342 that harbors in this
region a different 115 kbp insertion containing genes
related to its symbiotic lifestyle. Compared to NTUH-
K2044 each strain carries unique segments within this
RGP: in Kp13, this unique region is 12 kbp-long and con-
tains several uncharacterized genes (KP04788-KP04791)
(Figure 2). Since this ICE is usually found in more virulent
strains, the search for this region in other Enterobacteria-
ceae strains isolated in Brazil may help to estimate its
frequency and importance in clinically relevant bacteria.
RGP7 represents an insertion found only in the chro-
mosomes of Kp13 and MGH 78578 and contains CDSs
with conserved domains at their predicted protein sequence
such as glycosyltransferase (KP05060), acyltransferase
(KP05301), two-component histidine kinase sensor
(KP05061, KP05062) and peptidase (KP05059). The
presence of kexD (KP05076) in this RGP called for special
attention, since this gene codes for the recently character-
ized multidrug efflux pump KexD, an inner membrane pro-
tein belonging to the RND family [25]. It was found to be
overexpressed in a number of multidrug-resistant K. pneu-
moniae isolates, and confered resistance to erythromycin,tetracycline, ethidium bromide and other drugs [25].
RGP12 contains Kp13-specific fimbriae and adhesins
genes (KP02150-KP02154) and this insertion occurs after
a tRNA gene for threonine. The aco operon (acoKABCD,
KP32150; KP02898-KP02901) involved in acetoin catabol-
ism [26] was also found in this region. It was detected in
all compared strains, except for MGH 78578.
The large number of RGPs detected in Kp13 relative
to the strains MGH 78578, NTUH-K2044 and 342 indi-
cate a complex pattern of gain and loss of genetic mater-
ial segments that occurred during the shaping of each of
the compared chromosomes throughout their evolution-
ary history. It is thought that such events occur more
frequently in pathogenic than in non-pathogenic bac-
teria, the genomes of the first group being regarded as
more unstable and rearrangement-prone [27].
Unique and shared genes between the compared
K. pneumoniae
We have analyzed the group of shared and unique genes
between Kp13, MGH 78578, NTUH-K2044 and 342 to
obtain insights that might explain their distinct virulence
and pathogenic features.
The results from this analysis are shown in Figure 3
and in Additional file 4. As expected, the majority of the
coding sequences from the compared organisms are part
of a conserved genomic ‘core’ comprising 4,269 CDSs
(Figure 3). Of these, 98.8% are chromosomally located in
Kp13. As the chromosomes are generally more stable
replicons, it is not surprising that most of the conserved
genes were detected in this genetic replicon. Most of the
so-called ‘accessory’ genes, which are present or not in
bacterial strains, were found in plasmids of the com-
pared K. pneumoniae. In Kp13, 40% of its unique genes
(region XIV in Figure 3) were encoded in plasmids. The
largest part of these unique genes (693 CDSs) could not
have any functional clues attributed and were annotated
Figure 3 Unique and shared gene content among the genomes
of K. pneumoniae Kp13, NTUH-K2044, MGH 78578 and 342. The
roman numbers at each partial intersection correspond to the CDSs
in Additional file 4.
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for follow-up studies focusing on whether these genes
are in fact expressed and their possible roles.
Among the shared genes found only in clinical isolates
(region III in Figure 3) we detected CDSs whose prod-
ucts are related to phosphonate utilization (phn cluster,
KP00091 and adjacent genes in Kp13). These were previ-
ously studied in Klebsiella and may provide means to
use alternative phosphorus sources such as aminoethyl-
phosphonate, ethylphosphonate and methylphosphonate
[28]. A CDS coding for D-aminoacylase (dan, KP32221)
was also detected, and shared 49% identity with the
recently characterized protein from Achromobacter xylo-
soxidans subsp. denitrificans (BLASTP against [Swiss-
Prot:P72349]). This enzyme is involved in the conversion
of N-acyl-D-amino acids to D-amino acids and fatty
acids [29]. CDSs annotated as sulfatases were also found
only in the clinical K. pneumoniae studied (Kp13 loci
KP03498, KP03499), and their products may play a role
in sulphate utilization.
Most of the unique genes found in Kp13 (region XIV
in Figure 3) are related to MGEs such as transposases,
insertion sequences and phage genes (Additional file 4).
There are also CDSs whose products are involved in
capsule formation (cps cluster) such as glycosyltrans-
ferases (KP03791, KP03802 and KP03803), which are
unique to Kp13. The structure of this cluster was previ-
ously studied and belonged to a hitherto unreported
capsular serotype [12]. CDSs whose predicted proteins
have similarity to fructosamine deglycase (KP01294, 40%
BLASTP identity to Bacillus subtilis [Swiss-Prot:O32157])
and fructosamine kinase (KP01295, 43% identity to
[Swiss-Prot:O32153]) were also unique to Kp13. These
enzymes are usually involved in the utilization of Amadori
products, and fructosamine itself is produced via the
condensation of glucose with amine compounds [30]. Weformulated the hypothesis that, if indeed the products of
these CDSs play a role in fructosamine metabolism as
energy source, they could provide the Kp13 isolate with
an adaptive advantage in the nosocomial setting, since
Amadori products are intimately related to advanced
glycation end-products (AGEs). In turn, AGEs are pro-
duced as result of poorly controlled chronic diseases
such as diabetes [31], and from this perspective these
compounds could enter the bacterial cell through an adja-
cent transporter coded in CDS KP01297 and be converted
into glucose by the aforecited enzymes, providing Kp13
with an alternative energy source within the compromised
host. In fact, Kp13 was recovered from a blood culture
of a diabetic patient. However, additional studies, using
animal models, are required to establish the occurrence of
increased frequency and/or exacerbation of Kp13-infection
in hyperglycemia. Another set of unique genes found in
Kp13 included the cassettes sat (KP32246, located in plas-
mid pKP13d), coding for streptothricin acetyltransferase
involved in the resistance to streptothricin antibiotics in
the context of a class 2 integron, and a CDS whose
product may be related to dihydrofolate reductase activ-
ity (KP31590, located in plasmid pKP13f within a class 1
integron), which may confer resistance to trimethoprim.
The latter will be further discussed in the context of
blaCTX-M-2.
Virulence- and resistance-related ‘weapons’ identified in
Kp13
Siderophores
Iron scavenging is important within the mammalian host
environment since its free form is usually found at very
low concentrations under physiological conditions [32].
Iron-acquisition systems were previously studied in other
strains including NTUH-K2044 and have been associated
with increased virulence [33,34]. The list of siderophore
systems found in Kp13 is presented in Additional file 5.
We have identified genes coding for proteins respon-
sible for the conversion of chorismic acid into entero-
bactin (entABEC cluster, KP03396 and adjacent CDSs)
as well as for the transport of this siderophore, which is
ubiquitously found among enterobacteria (fep cluster,
KP31892 and adjacent CDSs). The FhuABCD system was
also found in Kp13 (coded by CDSs KP01825-KP01828)
and is involved in the uptake of ferrichrome, a fungal sid-
erophore [35]. We have also found the genetic apparatus
needed for yersiniabactin synthesis, which was previously
discussed on the context of the plasticity region RGP5.
Another siderophore receptor homolog (the product of
CDS KP04902) displaying 70% identity to the aerobactin
receptor IutA (BLASTP against [SwissProt:P14542]) was
found, and could also represent a way for Kp13 to incorp-
orate exogenous chelating compounds since the iucABCD
cluster was not present in this strain, although it was
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pK2044_01340 and adjacencies). Other siderophore-
independent iron uptake systems in Kp13 include the
hmuRSTUV cluster (KP02540-KP02544), which prob-
ably code for an ABC family heme transporter; the feo
(ferrous iron transport) cluster, which synthesizes three
proteins (KP31748, KP00683, KP00684) involved in Fe2+
capture; and the sitABCD system, also from the ABC
family of proteins involved in the transport of divalent
cation such as Mn2+ and Fe2+; found in CDSs KP02550-
KP02553, respectively. The diverse repertoire of iron up-
take system detected in Kp13 likely influence its ability to
cause infection and survive within the human host.
Adhesins
The expression of adhesins is important during the
colonization stage when diverse mechanical forces such as
peristalsis and salivary secretion all act to hamper bacterial
invasion within the host [36]. The list of adhesins detected
in K. pneumoniae Kp13 and related bacteria is found in
Additional file 6. Most of the genes coding for these pro-
teins were found in all K. pneumoniae strains compared,
except for a fimbrial cluster present in a previously dis-
cussed plasticity region (RGP12).
Type 1 fimbriae coding genes were detected in Kp13,
including the fim cluster (KP02223 and adjacent genes).
Their products were previously reported as enhancing
virulence during urinary tract infection caused by K. pneu-
moniae [37]. The mrk cluster composed by five genes
(mrkABCDF, Additional file 6) that code for type 3 fim-
briae is also present in Kp13. In K. pneumoniae, type 3
fimbriae have been identified as accessories mediating the
formation of biofilms on biotic and abiotic surfaces such
as catheters in the hospital environment [38].
Apart from type 1 (fim) and type 3 (mrk) fimbrial ad-
hesins, we also identified in Kp13 six other clusters re-
lated to the expression of these virulence factors which
were previously studied in strain NTUH-K2044 [39]:
kpa (KP00426-KP00430), kpb (KP00500-KP00503), kpd
(KP03577-KP03580), kpe (KP05219-KP05222), kpf (KP0
2456-KP02459) and kpg (KP02460; KP05178; KP04093).
As has been previously observed [39], strain 342 lacks
the kpf cluster which was found in the clinical isolatesTable 3 Characteristics of the beta-lactamases identified in th
Product Gene CDS Gen
Beta-lactamase SHV-12 blaSHV12 KP32248 pKP
Beta-lactamase OXA-9 blaOXA9 KP01389 pKP
Beta-lactamase TEM-1 blaTEM-1 KP01391 pKP
Beta-lactamase CTX-M-2 blaCTX-M-2 KP03128 pKP
Beta-lactamase SHV-110 blaSHV110 KP31849 Chr
Beta-lactamase KPC-2 blaKPC-2 KP06703 pKP
*,BLASTP against the NCBI database; Chr, chromosome; nd, not determined; pKP13[and is composed by genes coding for a fimbrial subunit
(KP02456), a chaperone (KP02457), an usher protein
(KP02458) and an adhesin (KP02459). Since strain 342
occupies a distinct ecological niche, further studies are
warranted to determine the implications of kpf expres-
sion to the pathogenesis of clinical K. pneumoniae.
The identification of different adhesin clusters, includ-
ing one previously unreported, should be important for
the control of Kp13 and related pathogenic bacteria,
as these proteins have been already proposed as good
vaccine candidates [40].
Enzymatic inactivation of antimicrobials
The resistance determinant blaSHV gene, which codes a
narrow-spectrum class A beta-lactamase known to con-
fer the intrinsic resistance to amoxicillin, ampicillin,
ticarcillin and carbenicillin, was identified in Kp13 [41].
Indeed, both K. pneumoniae MGH 78578 and NTUH-
K2044 genomes contain a blaSHV-11 copy, encoding the
narrow-spectrum SHV variant. Kp13 showed two copies
of blaSHV genes: blaSHV-12 (found in the plasmid pKP13f)
encoding an extended-spectrum beta-lactamase (ESBL);
and a chromosomally-encoded blaSHV-110 gene coding for
an enzyme whose spectrum of activity has not been char-
acterized yet (Table 3). The blaSHV-12 copy was located
downstream an IS26 element (KP05944), while blaSHV-110
was found downstream the lac operon and was followed
by an uncharacterized HTH-type transcriptional regulator
CDS (KP01127).
Several acquired beta-lactamase-encoding genes were
identified in plasmids pKP13f and pKP13d of Kp13, namely
blaTEM-1, blaOXA-9, blaCTX-M-2, and blaKPC-2 (Table 3),
genes that if properly expressed are enough to confer
resistance to all beta-lactam agents. blaTEM-1 encodes
a class-A beta-lactamase with limited spectrum of ac-
tivity, that confers resistance against penicillins and
first-generation cephalosporins and whose activity is
inhibited by clavulanic acid [42]. The blaOXA-9 gene
probably encodes a class-D beta-lactamase with narrow
spectrum of activity, although its complete biochemical
characterization remains to be determined. OXA-9 is
inhibited by clavulanic acid and cloxacillin, but dif-
ferently from most OXA enzymes is not inhibited bye Kp13 genome
etic element Best hit (% identity*, isolation country)
13f K. pneumoniae MGH 78578 (100%, USA)
13f K. pneumoniae FC1 (100%, Argentine)
13f Neisseria gonorrhoeae (100%, nd)
13f Salmonella typhimurium CAS-5 (100%, Argentine)
K. pneumoniae FSP 237/05 (100%, Brazil)
13d K. pneumoniae 15 (100%, USA)
d/f], plasmid pKP13d/pKP13f.
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production [43]. The blaCTX-M-2 gene encodes an ESBL
commonly observed in Enterobacteriaceae isolates from
humans, swine and poultry manure, although this gene
has also been identified in P. aeruginosa, Vibrio cholerae
and Acinetobacter baumannii clinical isolates [44]. In
Kp13, blaCTX-M-2 is found downstream a class 1 integrase
CDS (KP03119) and adjacent to the Orf513-coding gene
(KP03126), also named ISCR1, which possibly mediates
the dissemination of this gene [45]. As previously de-
scribed [45], this integron contains a duplication of its 3′
segment where truncated qacE (between CDSs KP18328
and KP03130) and sul1 (KP03130 and KP03134) were
found. The overall architecture of the blaCTX-M-2 region in
Kp13 is closer to that described for the class 1 integron
harboring blaCTX-M-59 (termed In0506) recovered from
patients in São Paulo, Brazil [46], with which the Kp13 se-
quence shares 99% identity (BLASTN against GenBank
accession no. EU622856), and the difference relies on the
non-synonymous change in blaCTX-M-2. This region also
carries resistance determinants to other antimicrobial
classes, including the genes dfrXVb (KP31590), encod-
ing an alternative dihydrofolate reductase that is associ-
ated with resistance to trimethoprim and a cmlA-like
(KP18323), which codes for an efflux pump related to
chloramphenicol resistance [47]. Of special interest in
Kp13 was the detection of blaKPC-2 (KP06703, found in
pKP13d) gene coding for the K. pneumoniae class A
carbapenemase (KPC-2). The expression of KPC-2, es-
pecially when associated with porin alterations, can give
rise to resistance against all beta-lactams. The genetic
context of blaKPC-2 includes an upstream insertion se-
quence (ISKpn6, KP06702), as well as a resolvase CDS
(Figure 4). It is of notice that no inverted repeats related to
Tn4401 were detected, since this transposon is frequently
associated with the mobilization of the carbapenemaseFigure 4 Genetic context of blaKPC-2 in K. pneumoniae Kp13. Genes are
transcriptional direction). Some structures of this region are highlighted, su
inverted repeats flanking ISKpn6 (depicted as black triangles). Also shown a
(T1, T2) identified using the ARNold webserver [49] and their correspondinggene [48]. The absence of such signals can be regarded as
evidence that the spread of blaKPC-2 also occurs solely by
recombination events involving ISKpn6 and the flanking
Tn3-family sequences.
Resistance by target alteration
Mutations in specific sites in genes coding for proteins
used as targets for antimicrobials, such as GyrA and ParC,
can result in decreased drug sensitivity. Kp13 showed the
double substitutions Ser83→ Phe and Asp87→Asn in
GyrA (KP00955) which are known to confer ciprofloxacin
resistance [50]. Also, a single amino acid change, Ser80→
Ile, was detected in ParC (KP02784), and the combined
effect of these mutations could have contributed to the
high-level resistance to quinolones displayed by Kp13 as
has been shown for other pathogenic bacteria [51]. MGH
78578 carries the Ser83→Tyr mutation in GyrA, while in
NTUH-K2044 no mutations in this gene were detected.
No changes in the ParC quinolone resistance-determining
region were detected in these strains.
Another well recognized resistance mechanism by tar-
get alteration is the expression of 16S rRNA methyl-
transferases. These enzymes transfer methyl radicals to
certain nitrogenous bases located at the A site of 16S
rRNA in the 30S portion of the ribosome and confers re-
sistance to most clinically-relevant aminoglycosides [52].
Kp13 harbored the rmtG gene (KP01427) in plasmid
pKP13f, which encodes a 16S rRNA methyltransferase
recently described from a K. pneumoniae clinical isolate
from Brazil [53]. Immediately upstream this gene a puta-
tive tRNA ribosyltransferase CDS (KP01428) was found.
A CDS annotated as a transposase (KP01425) is located
close to the 3′-end of rmtG, and search against the
ISFinder database classified this sequence in the IS91
family, although it is unclear whether this transposon is
involved in the mobilization of rmtG.depicted as horizontal arrows (orientations indicate their
ch as an inverted repeat right (IRR) of the Tn3 transposon, as well as
re the localization of two rho-independent transcriptional terminators
sequences.
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We searched the genome of Kp13 and related K. pneu-
moniae for known MDR efflux pumps. Table 4 summa-
rizes these results, which include pumps belonging to
the five main families of efflux proteins. The tolC gene
coding for accessory protein TolC used by many systems
is found in CDS KP02796 in Kp13.
One of the main efflux-related resistance mechanisms
involves the expression of the acrAB genes, coding for a
periplasmic protein (AcrA, KP03629) and a transporter
protein (AcrB, KP03630) which use the aforecited TolC
channel. Expression of these genes is regulated by the
adjacent acrR gene (KP03628), as well as by marR, ramR
and soxR genes; mutations in these genes may result in
acrAB overexpression, thus contributing to the MDR
phenotype [55]. However, we did not detect alterations
in these genes, suggesting that other efflux systems inTable 4 Drug-related efflux pumps identified in compared K.
System CDSΔ Resistance profileΩ
RND family
AcrAB KP03628 AC, BL, BS, CM, CV, EB, FA, FQ, ML, NO, OS,
AcrD KP03833 AG, DC, FU, NO
KexD KP05076 EM, EB, NO, RD, TPP
MdtABC KP03148 BS, DC, NO
OqxAB KP02440 CM, FQ, NA, SDS
MF family
Bcr KP04395 BI, STZ
EmrAB KP31576 CCC, NA, TCS, TLM
Fsr KP03612 FM
MdfA (KdeA) KP04269 AG, BENZ, CM, EB, FQ, RF, TC
MdtG KP04943 DC, FOM
MdtH KP04933 ENX (FQ), NFX
MdtL KP32205 CM
SmvA KP04515 CV, EB
SMR family
EmrE KP32244 AC, CV, EB
SugE KP00509 BENZ, EB
MATE family
MdtK KP05135 AC, NFX
ABC family
MacAB KP04225 ML
MdlAB KP03663 ?
Δ, in the case where the pump is encoded by multiple CDSs, the ID corresponds to
Substrate nomenclature adapted from [54]: AC, acriflavine; AG, aminoglycosides; BI,
CCC, carbonyl cyanide chlorophenylhydrazone; CM, chloramphenicol; CV, crystal vio
FA, fatty acids; FQ, fluoroquinolones; FOM, fosfomycin; FM, fosmidomycin; FU, fusid
organic solvents; RD, rhodamine; RF, rifampicin; SDS, sodium dodecyl sulfate; STZ, s
TPP, tetraphenylphosphonium chloride; TX, Triton X-100; ?, regarded as related to m
BLASTP against the target genome.Kp13 might be involved in the extrusion of antimicrobials
(Table 4). Another well-studied efflux pump identified
in Kp13 and other compared K. pneumoniae strains is
OqxAB (coded in CDSs KP02440/KP02441), which was
first identified in E. coli plasmids. It has been widely
reported in K. pneumoniae clinical isolates, where it is
usually chromosomally located [56]. The expression of
oqxAB has been associated with resistance to quinolones
[57], and it remains to be investigated whether this system
contributes to the high-level fluoroquinolones resistance
displayed by Kp13. Other efflux systems found in the
compared K. pneumoniae include homologs of AcrD
(RND family), MdfA and MdtH (both from the MF super-
family) (Table 4), involved in the efflux of aminoglycosides
and fluoroquinolones [58], compounds to which Kp13
displays resistance. The majority of the efflux pumps are
conserved among the different strains and most of thempneumoniae
Presence in
Kp13 NTUH-K2044 MGH 78578 342
RF, SDS, TX + + + +
+ + + +
+ − + −
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ + + +
+ − − −
+ + + +
+ + + +
+ + + +
+ + + +
one of the adjacent CDSs. Ω, based in the literature found for each system.
bicyclomycin; BL, beta-lactams; BS, bile salts; BENZ, benzalkonium chloride;
let; DC, deoxycholate; EB, ethidium bromide; EM, erythromycin; ENX, enoxacin;
ic acid; ML, macrolides; NA, nalidixic acid; NFX, norfloxacin; NO, novobiocin; OS,
ulfathiazole; TC, tetracycline; TCS, tetrachlorosalicylanilide; TLM, thiolactomycin;
ultidrug-resistance, but with an unknown resistance spectrum. *, evaluated by
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this qualitative conservation, we have identified several
non-synonymous mutations in various genes coding efflux
pumps in the Kp13 genome when compared with NTUH-
K2044 and MGH 78578 (see SNPs analysis section and
the table in Additional file 7), although whether these
alterations change the specificity profile of these systems
remains an open question.
We studied the common porins present in K. pneumo-
niae bacteria, namely OmpK35 (homolog to OmpF in
E. coli) and OmpK36 (the OmpC homolog). In strain Kp13,
the genes coding for these proteins are found in CDSs
KP04180 and KP00950, respectively. While we observed an
overall conservation at the gene sequence level between
Kp13 and the compared strains for both ompK35/ompK36,
a peculiarity in the chromosome of Kp13 in the region
upstream ompK35 was detected with the insertion of an
IS1380 family transposase (KP04179), which does not occur
in the compared K. pneumoniae strains. Multiple alignment
of this region and in silico promoter search suggested that
this recombination event disrupted the probable promoters
needed for ompK35 expression (see Additional file 8 [A]).
Experimental evidence corroborating this hypothesis
was obtained by the extraction and analysis of outer
membrane (OM) proteins using SDS-PAGE [59], where
OmpK35 was not visualized (Additional file 8 [B]).
Porin loss was previously studied in K. pneumoniae and
the non-expression of ompK35 was associated with in-
creased resistance to antibiotics such as cephalosporins
and cephamycins [60]. Thus, loss of OmpK35 appears
to be another mechanism employed by strain Kp13 that
contributed to its MDR profile.
Polymyxin B is a rapid-acting bactericidal agent that
interacts with the OM lipopolysaccharide (LPS) in Gram-
negative bacteria. It was recently shown that the two-
component systems PhoPQ and PmrAB together with
the Rcs system govern polymyxin-induced transcriptional
changes, and that there is a cross talk between PhoPQ and
the Rcs system [61]. In the genome of Kp13, we identified
all these regulatory systems: PhoQP (in CDSs KP04870,
KP04869), PmrAB (in CDSs KP03034, KP3033) and
RcsBCD (in CDSs KP00953, KP00954, KP00952). Tran-
scriptional studies are ongoing to determine the regulons
networks that govern polymyxin B-induced changes in
Kp13.
Interstrain variation at the nucleotide level may relate to
lifestyle-specific adaptations
SNPs were determined for three comparisons using the
complete chromosome sequence of Kp13 as reference
aligned against: i) the complete chromosome sequence
of strain MGH 78578, ii) complete chromosome sequence
of strain NTUH-K2044 and iii) complete chromosome se-
quence of strain 342. The number of SNPs falling withinnon-coding and coding regions (non-synonymous, syn-
onymous and non-sense) between each comparison are
listed in Figure 5A. It can be seen that strain 342 accumu-
lated a total number of mutations much larger than the
other two strains in comparison to Kp13 (data not shown).
This result is in accordance with the proposed hypothesis
that this strain should be reclassified as K. variicola [62].
Then, we investigated the common SNPs identified in all
CDSs of Kp13 (grouped according to their COG func-
tional category) against both pathogenic strains, MGH
78578 and NTUH-K2044 (Figure 5B and Additional file
9). These SNPs represented unique Kp13 alleles relative to
the latter two human pathogenic strains. Disregarding un-
informative categories such as general function prediction
and unknown function, the ones which accumulated more
SNPs were E (amino acid transport/metabolism) and G
(carbohydrate transport/metabolism). Also, 124 SNPs were
identified within CDSs related to category V (defense me-
chanisms). Subsequently, in order to understand the
significance of SNPs in relation to the Kp13 lifestyle, we in-
vestigated all SNPs falling within CDSs related to virulence
and resistance. Notably, most SNPs (141 in total) were
identified within CDSs involved in drug resistance (MDR/
DR) (Figure 5C, Additional file 7). They are followed by
CDSs whose products function as OM proteins, accounting
for 42 mutations, such as the CDS for an OmpA domain-
containing protein, which carries four non-synonymous
mutations (out of a total of 9) (Additional file 7). However,
the role of non-synonymous mutations found among CDSs
involved in drug resistance in K. pneumoniae remains
unknown.
The SNPs analysis performed in Kp13 relative to the
two other human pathogenic strains has shown that there
are Kp13-specific alleles occurring in many functional
COGs, suggestive that these SNPs could result in a variety
of diverse phenotypic effects. Moreover, the amount of
SNPs found in CDSs associated with drug resistance may
give additional clues on the distinctness of Kp13 compared
to MGH 78578 and NTUH-K2044. An interesting follow-
up for this study would be to analyze the relationship
between the amino acid sequence substitutions in these
proteins and their corresponding structural alterations,
which could relate to the resistance phenotype of Kp13.
As an example, non-synonymous mutations in possible
MDR-related genes were detected, such as in mdtB
(respective changes at the protein level Ile93→Met,
Ala352→Thr, Arg526→His, considering the Kp13 CDS
KP04638 as reference) and an acrB homolog (Thr511→
Ala, Val542→Ala) (Additional file 7).
Finally, the results from the SNPs analysis shed light
on the plasticity of the Kp13 genome at the nucleotide
level, which complement the observed plasticity at the
broader level of genomic segments, discussed within the
context of RGPs.
Figure 5 Single-nucleotide polymorphisms (SNPs) identified in K. pneumoniae Kp13 compared to MGH 78578, NTUH-K2044 and 342
strains. (A) Total number of SNPs falling within non-coding and coding regions (CDSs) when compared with the three other strains. synon,
synonymous. (B) Common SNPs falling within CDSs grouped by COG classification identified when compared with the strains NTUH-K2044 and
MGH 78578. (C) Selected common SNPs falling within virulence- and resistance-related CDSs identified when compared with the NTUH-K2044 and MGH
78578 strains. MDR/DR, multidrug resistance/drug resistance; LPS, lipopolysaccharide. Numbers after the slash indicates the number of non-synonymous
SNPs. COG classes single-letter abbreviations in panel B are: B (chromatin structure), C (energy production/conversion), D (cell division/chromosome
partitioning), E (amino acid transport/metabolism), F (nucleotide transport/metabolism), G (carbohydrate transport/metabolism), H (coenzyme transport/
metabolism), I (lipid transport/metabolism), J (translation/ribosomal structure), K (transcription), L (replication/recombination/repair), M (cell wall/membrane/
envelope biogenesis), N (cell motility), O (posttranslational modification/protein turnover/chaperones), P (inorganic ion transport/metabolism), Q (secondary
metabolite biosynthesis/transport/catabolism), R (general function prediction), S (function unknown), T (signal transduction), U (intracellular trafficking/
secretion), V (defense mechanisms).
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We have thoroughly mined the genome of K. pneumoniae
strain Kp13, which to our best knowledge is the first com-
pletely determined and closed genome of a K. pneumoniae
representative involved in a large hospital outbreak. The
Kp13 genome is composed by one chromosome and six
plasmids of variable sizes. They harbor multiple resistance
and virulence loci, coding a diverse range of siderophores,
efflux pumps, beta-lactamases and adhesins that might
contribute to the succesfull adaptation of this strain to the
hospital environment. We also identified alterations in the
porin profile of Kp13, which were confirmed experimen-
tally. Multiple regions of genomic plasticity were detectedin this strain including the yersiniabactin high patho-
genicity island and T6SS-related loci, which could be
propagating through HGT to related bacteria. Although
the compared genomes present an overall conserved
architecture, we have demonstrated the singular charac-
teristics of Kp13 that differentiates this strain from
previously studied K. pneumoniae and may have con-
tributed to its fitness and succesfull spread on the hos-
pital environment. Within the context of chromossomal
architecture and RGPs analyses, we might also assume
that the major force that models the genomes of the
compared K. pneumoniae strains is HGT instead of gen-
omic rearrangements. Moreover, the genome plasticity
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lysis, from the broader, whole genome structure context,
to the finer level of single-nucleotide polymorphisms.
Methods
Ethics statement
The Ethics Committee of the Universidade Estadual de
Londrina (UEL) approved the present study under refer-
ence number CAAE:3356.0.000.268-09. Clinical evaluation
and blood sampling were performed after diagnostic rou-
tine procedures in the intensive care unit of the Hospital
Universitário (UEL) with written informed consent of the
patient.
Bacterial strain
Klebsiella pneumoniae isolate Kp13 was obtained from
the blood culture of a patient admitted to the intensive
care unit with diabetes mellitus and cranial encephalic
trauma [12]. This bacterium was isolated during an
event of nosocomial outbreak due to KPC-2-producing
K. pneumoniae that occurred at the Hospital Universi-
tário (UEL) between February and May 2009. The anti-
microbial susceptibility profile of Kp13 was confirmed
by broth microdilution. Antimicrobials tested included
ampicillin, amoxicillin/clavulanic acid, piperacillin/taz-
obactam, cefoxitin, ceftriaxone, ceftazidime, cefepime,
imipenem, meropenem, ertapenem, gentamicin, ami-
kacin, levofloxacin, polymyxin B and minocycline, and
tigecycline. MICs were determined and interpreted
following the CLSI guidelines for Enterobacteriaceae
[63,64] except for tigecycline and polymyxin B where
FDA [65] and EUCAST [66] breakpoints were applied,
respectively. Kp13 was susceptible to tigecycline (MIC,
0.25 mg/L) and minocycline (MIC, 2 mg/L), and displayed
resistance to ampicillin (MIC, >32 mg/L); amoxicillin/cla-
vulanic acid (MIC, >32/16 mg/L), piperacillin/tazobactam
(MIC, >128/4 mg/L), cefoxitin (MIC, >32 mg/L), ceftriax-
one (MIC, >64 mg/L), ceftazidime (MIC, >32 mg/L), cefe-
pime (MIC, >32 mg/L), ertapenem (MIC, ≥1024 mg/L),
imipenem (MIC, 64 mg/L); meropenem (MIC, 64 mg/L),
amicacin (MIC, >64 mg/L), gentamicin (MIC, 256 mg/L)
and polymyxin B (32 mg/L). In addition, this isolate showed
the carbapenemase producer phenotype and was confirmed
to carry the gene encoding KPC-2 [12].
DNA sequencing, genome assembly and annotation
Both shotgun and 3 kb paired-end library were constructed
and the genome sequencing of K. pneumoniae isolate
Kp13 was carried out using the Genome FLX sequencer
(454 Life Sciences/Roche), as previously described [12].
Genome assembly was performed using Newbler v 2.6
(Roche) and Celera genome assembly v 6.1 (JCV Institute).
Gaps within scaffolds resulting from repetitive sequences
were resolved by in silico gap filling. We achieved meansequence coverage of 111× for this genome. The SABIA
pipeline [67] was used for gene prediction and auto-
matic annotation followed by manual validation of each
predicted CDS.
MLST analysis
Multilocus sequence typing was performed as previ-
ously described [68]. Briefly, the trimmed nucleotide
sequences of seven housekeeping genes namely rpoB,
gapA, mdh, pgi, phoE, infB and tonB were analyzed
using the Klebsiella pneumoniae MLST Database, avail-
able at http://www.pasteur.fr/recherche/genopole/PF8/
mlst/Kpneumoniae.html. For each allele was given a
number that combined yielded the sequence type (ST).
The goeBURST algorithm was employed to generate a
minimum spanning tree using the information of iso-
lates available and the PHYLOViZ tool [69]. Clonal
complexes included STs sharing at least 5 identical alleles
between their representatives.
Comparative genomic analyses
The MicroScope platform [70,71] provided some of the
tools used for the comparative genomic analyses, such
as the RGPFinder and Phyloprofile modules for deter-
mination of regions of genomic plasticity (RGPs) and
unique/shared gene content identification, respectively.
RGPs are defined as DNA segments over 5 kbp possibly
related to events of horizontal exchanges, and they are
identified using a series of constraints such as G + C%
deviation, compositional biases as measured by the tools
Alien_Hunter [72] and SIGI-HMM [73], synteny breaks
and proximity to tRNAs. In these analyses, the Kp13
chromosome was set as the reference and RGPs were
searched relative to those of strains 342, MGH 78578
and NTUH-K2044. Each identified RGP was manually
inspected based on its genomic context and conserved
genes located at the flanks of the region. Elements char-
acteristic of horizontal transference events such as
tRNAs, transposases and prophage sequences were also
searched for within each region. EasyFig [74] was used
to generate comparative figures of specific regions, while
the BLAST Ring Image Generator 0.95 [75] was used to
plot the chromosome map as well as arrange and
visualize the RGPs within the overall Kp13 chromosome
context.
In order to identify unique and shared gene content,
the PhyloProfile Exploration tool within MaGe was used,
and the following criteria from Jenssen et al. [76] were
adopted to define orthology between two translated
open reading frames: (i) the smaller protein covering at
least 80% the length of the larger (minLrap ≥ 0.8); (ii)
protein identity ≥ 35%. A Venn diagram of the unique/
shared gene content was generated with a custom R
script using the package VennDiagram [77].
Ramos et al. BMC Genomics 2014, 15:54 Page 14 of 16
http://www.biomedcentral.com/1471-2164/15/54Chromosomal architecture comparison between K.
pneumoniae strains were carried out using the progressi-
veMauve algorithm implemented in Mauve 2.3.1 [78] at
its default parameters. For this analysis, sequences from
the chromosome of strains 342 [GenBank:CP000964],
MGH 78578 [GenBank:CP000647] and NTUH-K2044
[GenBank:AP006725] were downloaded from the NCBI
website and used as input to Mauve.
Phage-related sequences were searched using PHAST
[79], while T4SS-related sequences were scanned for using
the AtlasT4SS database [80].
The investigation of the resistance and virulence reper-
toire was facilitated by BLASTX sequence comparison
to the Antibiotic Resistance Genes Database [81], as well
as throughout the manual annotation of the Kp13 gen-
ome, when CDSs related to these functions were flagged.
Insertion sequences were characterized using the ISFin-
der database (http://www-is.biotoul.fr/) [82].
SNP analysis was carried out as previously described
[83]. Firstly, three primary SNP-call sets were generated
from comparisons between Kp13 and the strains MGH
78578, NTUH-K2044 and 342. Then, scripts in PERL
were written to function as quality filters to acquire the
most reliable SNP-call sets for the comparisons. Align-
ments were made using the NUCmer algorithm from
the MUMmer v.3.0 package [84]. SNPs were also classi-
fied regarding their location on intergenic region or
CDS (with its corresponding annotated function and
related COG category) [83].Nucleotide sequence accession numbers
The NCBI BioProject accession of K. pneumoniae Kp13
is PRJNA78291. The sequences reported here have been
deposited in the GenBank database (http://www.ncbi.
nlm.nih.gov/Genbank) under accession number [Gen-
Bank: CP003999] for the chromosome. The six plas-
mids are available under accession numbers [GenBank:
CP003996] (pKP13a), [GenBank: CP003994] (pKP13b),
[GenBank: CP003995], (pKP13c), [GenBank: CP003997]
(pKP13d), [GenBank: CP003998] (pKP13e) and [GenBank:
CP004000] (pKP13f).Additional files
Additional file 1: Chromosomal architecture of the four compared
K. pneumoniae isolates. Multiple alignments among the chromosomes
of Kp13, 342, NTUH-K2044 and MGH 78578 performed using the Mauve
software. Each line represents the linearized chromosome of the compared
strain. Rectangles in different colors represent locally colinear blocks (LCBs)
and homologous LCBs among strains are connected by vertical lines. The
white portions within LCBs do not exhibit correspondence in the compared
bacterial strains.
Additional file 2: Distribution of locally colinear blocks (LCBs) of K.
pneumoniae Kp13 relative to the NTUH-K2044, MGH 78578 and 342
strains.Additional file 3: Regions of genomic plasticity. Detailed analysis of
each RGP detected in the Kp13 chromosome.
Additional file 4: Shared and conserved genes between K.
pneumoniae strains 342, MGH 78578, NTUH-K2044 and Kp13. The
roman number labeling each spreadsheet corresponds to the partial
intersections indicated in Figure 4.
Additional file 5: Iron scavenging systems in compared K.
pneumoniae strains.
Additional file 6: Adhesins detected in compared K. pneumoniae
strains.
Additional file 7: Selected common SNPs falling within virulence- and
resistance-related CDSs identified in comparisons with the strains
NTUH-K2044 and MGH 78578.
Additional file 8: Multiple alignment of the region upstream
ompK35 in K. pneumoniae strains Kp13 and NVT2001 and outer
membrane proteins of Kp13. Panel A, The alignment was performed
relative to K. pneumoniae NVT2001, studied in [60]. The marked regions in
the sequence of NVT2001 correspond to those transferred by similarity from
ompF in E. coli by those authors, and include IHF (integration host factor),
RBS (ribosome binding site), the −10 and −35 promoters and the OmpR
binding sites (F1-F4) detected in NVT2001. Due to the transposase
recombination event that took place in Kp13, there are several differences
from the comparison with strain NVT2001 that should affect ompK35
expression in Kp13. Panel B, Sodium dodecyl sulfate-polyacrylamide gel
electrophoretic analysis of outer membrane proteins (OMPs) from Kp13
strain. Lanes 1 and 6, molecular marker weight; lane 2, K. pneumoniae control
strain 194 exhibiting intact OmpK35 and OmpK36 porins; lanes 3–5, OMP
profiles of Kp13 strain.
Additional file 9: Total number of common SNPs falling within
intergenic regions and CDSs grouped by COG classification identified
in comparisons with the strains NTUH-K2044 and MGH 78578.
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